BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

481 related articles for article (PubMed ID: 7340717)

  • 21. [What does the Krypto-Haem test accomplish in occult hemorrhage from the large intestine?].
    Klug W; Knoch HG
    Z Arztl Fortbild (Jena); 1983; 77(12):516-9. PubMed ID: 6603720
    [No Abstract]   [Full Text] [Related]  

  • 22. [Early diagnosis of colorectal cancer in the aged (author's transl)].
    Weiss W
    Aktuelle Gerontol; 1980 Feb; 10(2):79-87. PubMed ID: 6106409
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Occult blood screening for colorectal cancer].
    Kumanishi Y; Fujita M; Taguchi T
    Gan To Kagaku Ryoho; 1986 Jul; 13(7):2255-62. PubMed ID: 3729485
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Screening test for colorectal cancer. Practical experiences with fecal testing for occult blood. 2: Rate of a false-negative occult blood test].
    Schellenberger U; Raabe A; Erler K
    Z Arztl Fortbild (Jena); 1987; 81(20):1057-9. PubMed ID: 3433823
    [No Abstract]   [Full Text] [Related]  

  • 25. [Colonic cancer screening with KRYPTO-HAEM SSW. The results in 3015 persons].
    Uhlig K; Lampe J; Jacobasch KH; Wiedemann FH
    Arch Geschwulstforsch; 1983; 53(6):571-7. PubMed ID: 6670915
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Acceptability and compliance in screening for colorectal cancer with fecal occult blood test.
    Adamsen S; Kronborg O
    Scand J Gastroenterol; 1984 Jun; 19(4):531-4. PubMed ID: 6463577
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Performance characteristics and evaluation of an automated-developed and quantitative, immunochemical, fecal occult blood screening test.
    Vilkin A; Rozen P; Levi Z; Waked A; Maoz E; Birkenfeld S; Niv Y
    Am J Gastroenterol; 2005 Nov; 100(11):2519-25. PubMed ID: 16279909
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The use of a cancer registry in a mass screening program for colorectal cancer.
    Michalek AM; Cummings KM; Gamble D
    Cancer Detect Prev; 1988; 11(3-6):353-7. PubMed ID: 3390856
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Accuracy of occult blood tests over a six-day period.
    Farrands PA; Hardcastle JD
    Clin Oncol; 1983 Sep; 9(3):217-25. PubMed ID: 6616996
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The French National Society of Gastroenterology recommends systematic organized screening for colorectal cancer in France].
    Bretagne JF; Faivre J
    Gastroenterol Clin Biol; 2000 May; 24(5):492-3. PubMed ID: 10891735
    [No Abstract]   [Full Text] [Related]  

  • 31. An epidemiological study evaluating the relationship of distance from a tertiary care cancer center to early detection of colorectal carcinoma.
    Koka VK; Potti A; Fraiman GN; Hanekom D; Hanley JF
    Anticancer Res; 2002; 22(4):2481-3. PubMed ID: 12174948
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characteristics of rectosigmoid adenomas as predictors of synchronous advanced proximal colon neoplasms.
    Papatheodoridis GV; Triantafyllou K; Tzouvala M; Paspatis G; Xourgias V; Karamanolis DG
    Am J Gastroenterol; 1996 Sep; 91(9):1809-13. PubMed ID: 8792703
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Screening for colorectal cancer based on our experience with early colorectal cancer and adenoma].
    Miyazaki I; Takashima S; Takigawa Y; Kosaka T; Ueno K
    Gan No Rinsho; 1985 Jan; 31(1):52-6. PubMed ID: 3981802
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The detection of asymptomatic colorectal cancer.
    Miller SF
    Am Fam Physician; 1978 Sep; 18(3):89-92. PubMed ID: 685802
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Surveillance for colorectal cancer in average-risk patients, familial high-risk groups, and patients with adenomas.
    Winawer SJ; Sherlock P
    Cancer; 1982 Dec; 50(11 Suppl):2609-14. PubMed ID: 7139555
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Does prolonging the test period improve screening for colorectal cancer?].
    Hammes PH; Gnauck R
    Z Gastroenterol; 1987 Sep; 25(9):607-11. PubMed ID: 3673146
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Screening for colorectal cancer: the rationale and a recent advance in the detection of fecal occult blood.
    Friend WG
    Prog Clin Biol Res; 1985; 186():65-76. PubMed ID: 4034607
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Screening for colorectal carcinoma in a rural area.
    Heeb MA; Ahlvin RC
    Surgery; 1978 May; 83(5):540-1. PubMed ID: 644446
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Subsite distribution of colorectal carcinoma and implications for screening; a retrospective audit of 1771 cases.
    Erkek B; Ozkan N; Bayar S; Genc V; Ekrem U; Kuzu A; Aribal D
    Hepatogastroenterology; 2007; 54(73):77-80. PubMed ID: 17419235
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Currently recommended use of the Hemoccult for the detection of rectocolic tumors].
    Ribet A
    Sem Hop; 1982 Sep; 58(33):1877-9. PubMed ID: 6293064
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.